JP2008528512A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008528512A5 JP2008528512A5 JP2007552375A JP2007552375A JP2008528512A5 JP 2008528512 A5 JP2008528512 A5 JP 2008528512A5 JP 2007552375 A JP2007552375 A JP 2007552375A JP 2007552375 A JP2007552375 A JP 2007552375A JP 2008528512 A5 JP2008528512 A5 JP 2008528512A5
- Authority
- JP
- Japan
- Prior art keywords
- kda
- molecular weight
- isolated
- polypeptide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64610605P | 2005-01-21 | 2005-01-21 | |
| PCT/US2006/002474 WO2006079076A2 (en) | 2005-01-21 | 2006-01-20 | Yersinia spp. polypeptides and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012209231A Division JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアspp.ポリペプチド及び使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008528512A JP2008528512A (ja) | 2008-07-31 |
| JP2008528512A5 true JP2008528512A5 (enExample) | 2009-03-12 |
Family
ID=36649588
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007552375A Withdrawn JP2008528512A (ja) | 2005-01-21 | 2006-01-20 | エルシニアspp.ポリペプチド及び使用方法 |
| JP2012209231A Expired - Fee Related JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアspp.ポリペプチド及び使用方法 |
| JP2015139060A Expired - Fee Related JP6224655B2 (ja) | 2005-01-21 | 2015-07-10 | エルシニアspp.ポリペプチド及び使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012209231A Expired - Fee Related JP6178059B2 (ja) | 2005-01-21 | 2012-09-24 | エルシニアspp.ポリペプチド及び使用方法 |
| JP2015139060A Expired - Fee Related JP6224655B2 (ja) | 2005-01-21 | 2015-07-10 | エルシニアspp.ポリペプチド及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US8563004B2 (enExample) |
| EP (3) | EP2431382A1 (enExample) |
| JP (3) | JP2008528512A (enExample) |
| CN (1) | CN101142230A (enExample) |
| AU (1) | AU2006206234B2 (enExample) |
| BR (1) | BRPI0606506A2 (enExample) |
| CA (1) | CA2595163A1 (enExample) |
| DK (1) | DK1848732T3 (enExample) |
| ES (1) | ES2588010T3 (enExample) |
| MX (1) | MX2007008723A (enExample) |
| NZ (1) | NZ556651A (enExample) |
| WO (1) | WO2006079076A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2279511T3 (es) * | 1994-02-09 | 2007-08-16 | Epitopix Llc | Inmunizacion activa utilizando una proteina receptor de sideroforo. |
| US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| DK1353689T3 (da) * | 2001-01-03 | 2006-07-31 | Epitopix Llc | Immuniseringspræparater og anvendelse deraf |
| US8329192B2 (en) | 2003-09-19 | 2012-12-11 | Epitopix Llc | Campylobacter polypeptides and methods of use |
| CA2595163A1 (en) | 2005-01-21 | 2006-07-27 | Epitopix, Llc | Yersinia peptides grown in media comprising 2,2'-dipyridyl, compositions and kits thereof |
| KR102211724B1 (ko) | 2011-05-31 | 2021-02-03 | 허치슨 바이오필름 메디컬 솔루션스 리미티드 | 세포 응집물의 분산 및 분리 |
| US9631221B1 (en) * | 2011-09-02 | 2017-04-25 | Becton, Dickinson And Company | Identification of microorganisms using MALDI-TOF-MS on-plate extraction |
| WO2013099806A1 (ja) | 2011-12-29 | 2013-07-04 | Taoヘルスライフファーマ株式会社 | アミロスフェロイドが結合して成熟神経細胞死を誘発する標的分子、アミロスフェロイドが誘導する神経細胞死を抑制する方法及び物質、及びそれらの利用 |
| US9701760B2 (en) * | 2012-02-13 | 2017-07-11 | National University Corporation Kyoto Institute Of Technology | Peptide having affinity for silicon nitride (Si3N4), and use therefor |
| US8753643B1 (en) | 2012-04-11 | 2014-06-17 | Life-Science Innovations, Llc | Spray dried compositions and methods of use |
| US9017953B2 (en) * | 2012-05-18 | 2015-04-28 | Washington University | Biomarker and therapeutic for urinary tract infection |
| RU2549712C1 (ru) * | 2013-11-26 | 2015-04-27 | Федеральное казенное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | CПОСОБ ВЫДЕЛЕНИЯ ИНГИБИТОРА СЕКРЕЦИИ СИДЕРОФОРОВ, СИНТЕЗИРУЕМОГО pgm- ШТАММАМИ Y. pestis И ВЫДЕЛЕННЫЙ ИНГИБИТОР |
| FR3024903A1 (fr) | 2014-08-14 | 2016-02-19 | Biomerieux Sa | Procede de quantification d'au moins un groupe de microorganismes par spectrometrie de masse |
| WO2016058007A2 (en) * | 2014-10-10 | 2016-04-14 | Rare Element Resources, Ltd. | Processing for the extraction of rare earth elements |
| PT3247728T (pt) | 2015-01-20 | 2020-07-16 | Igm Biosciences Inc | Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas |
| EP3373964A1 (en) | 2015-11-09 | 2018-09-19 | Epitopix, LLC | Polypeptides of fusobacterium and methods of use |
| US10166280B2 (en) | 2016-06-08 | 2019-01-01 | Epitopix, Llc | Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use |
| MX2019009409A (es) | 2017-02-10 | 2019-09-27 | Epitopix Llc | Proteinas y composiciones de inmunizacion que contienen proteinas de pasteurella y metodos de uso. |
| AU2020367821A1 (en) * | 2019-10-18 | 2022-05-12 | University Of Utah Research Foundation | Polymeric drug delivery conjugates and methods of making and using thereof |
| CN113679829B (zh) * | 2020-05-18 | 2024-01-02 | 北京繁易纳维科技有限公司 | 一种预防癌症术后复发的肿瘤疫苗及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420253A (en) | 1993-09-09 | 1995-05-30 | Willmar Poultry Company, Inc. | Method for purifying egg yolk immunoglobulins |
| ES2279511T3 (es) * | 1994-02-09 | 2007-08-16 | Epitopix Llc | Inmunizacion activa utilizando una proteina receptor de sideroforo. |
| US5830479A (en) | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| AU1860095A (en) | 1994-03-22 | 1995-10-09 | Pfizer Inc. | (pasteurellaceae) antigens and related vaccines |
| US5538733A (en) | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
| WO1998024912A2 (en) * | 1996-12-04 | 1998-06-11 | Heska Corporation | Recombinant plague vaccine |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6610836B1 (en) | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
| EP1268774A2 (en) | 2000-03-21 | 2003-01-02 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
| DK1353689T3 (da) | 2001-01-03 | 2006-07-31 | Epitopix Llc | Immuniseringspræparater og anvendelse deraf |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0127657D0 (en) * | 2001-11-19 | 2002-01-09 | Microscience Ltd | Virulence genes and proteins and their use |
| CN1674933B (zh) * | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| US8329192B2 (en) | 2003-09-19 | 2012-12-11 | Epitopix Llc | Campylobacter polypeptides and methods of use |
| DE602005025647D1 (de) * | 2004-07-23 | 2011-02-10 | Novartis Vaccines & Diagnostic | Polypeptide für die oligomerisierung von antigenen |
| EP1784417B1 (en) | 2004-08-25 | 2016-05-18 | Epitopix, LLC | Fusobacterium polypeptides and methods of use |
| CA2595163A1 (en) | 2005-01-21 | 2006-07-27 | Epitopix, Llc | Yersinia peptides grown in media comprising 2,2'-dipyridyl, compositions and kits thereof |
| JP2008530245A (ja) | 2005-02-18 | 2008-08-07 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | 尿路病原性菌株由来の抗原 |
| WO2006113907A2 (en) * | 2005-04-20 | 2006-10-26 | The General Hospital Corporation | Escherichia coli o157:h7 proteins and uses thereof |
-
2006
- 2006-01-20 CA CA002595163A patent/CA2595163A1/en not_active Abandoned
- 2006-01-20 JP JP2007552375A patent/JP2008528512A/ja not_active Withdrawn
- 2006-01-20 EP EP11007570A patent/EP2431382A1/en not_active Withdrawn
- 2006-01-20 EP EP06719369.8A patent/EP1848732B1/en not_active Expired - Lifetime
- 2006-01-20 MX MX2007008723A patent/MX2007008723A/es active IP Right Grant
- 2006-01-20 DK DK06719369.8T patent/DK1848732T3/en active
- 2006-01-20 CN CNA2006800028566A patent/CN101142230A/zh active Pending
- 2006-01-20 ES ES06719369.8T patent/ES2588010T3/es not_active Expired - Lifetime
- 2006-01-20 WO PCT/US2006/002474 patent/WO2006079076A2/en not_active Ceased
- 2006-01-20 NZ NZ556651A patent/NZ556651A/en not_active IP Right Cessation
- 2006-01-20 US US11/336,706 patent/US8563004B2/en active Active
- 2006-01-20 AU AU2006206234A patent/AU2006206234B2/en not_active Ceased
- 2006-01-20 BR BRPI0606506-6A patent/BRPI0606506A2/pt not_active Application Discontinuation
- 2006-01-20 EP EP11075020A patent/EP2361926A3/en not_active Withdrawn
-
2011
- 2011-01-31 US US13/018,292 patent/US20110206674A1/en not_active Abandoned
-
2012
- 2012-09-24 JP JP2012209231A patent/JP6178059B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-08 US US14/048,649 patent/US9085613B2/en not_active Expired - Lifetime
- 2013-10-08 US US14/048,643 patent/US9109018B2/en not_active Expired - Lifetime
- 2013-10-08 US US14/048,640 patent/US9085612B2/en not_active Expired - Lifetime
-
2015
- 2015-07-07 US US14/793,494 patent/US9221899B2/en not_active Expired - Lifetime
- 2015-07-10 JP JP2015139060A patent/JP6224655B2/ja not_active Expired - Fee Related
- 2015-11-05 US US14/933,899 patent/US9352029B2/en not_active Expired - Lifetime
-
2016
- 2016-04-28 US US15/140,767 patent/US9801932B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240056564A (ko) | T 세포 림프종을 치료하기 위한 약물을 제조하는 데 있어서 ezh2 억제제의 용도 | |
| Chowdhury et al. | Natural peste des petits ruminants virus infection in Black Bengal goats: virological, pathological and immunohistochemical investigation | |
| Nagib et al. | Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats | |
| Levendosky et al. | Griffithsin and carrageenan combination to target herpes simplex virus 2 and human papillomavirus | |
| EA200971130A1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| Traboulsi et al. | The flavonoid isoliquiritigenin reduces lung inflammation and mouse morbidity during influenza virus infection | |
| EA035372B1 (ru) | Флагеллиновые композиции и их применение | |
| NO20075046L (no) | Gastroresistente farmasoytiske formuleringer inneholdende rifaximin | |
| JP2008523153A5 (enExample) | ||
| KR102299635B1 (ko) | 염증성 장질환의 치료에 있어서의 아르테미시닌 유도체의 의학적 용도 | |
| JP2005537234A5 (enExample) | ||
| NZ617196A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels | |
| Sauerhering et al. | Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice | |
| JP2009545526A5 (enExample) | ||
| Branche et al. | Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection | |
| JP2018524354A (ja) | 大腸炎を処置する方法 | |
| Manns et al. | Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase II b and III studies | |
| KR102548616B1 (ko) | 관중 유래 화합물 또는 이의 유도체를 포함하는 코로나바이러스 감염 예방 및 치료용 약학 조성물 | |
| JP2006511538A5 (enExample) | ||
| Li et al. | Lasso peptide MccY alleviates non-typhoidal salmonellae-induced mouse gut inflammation via regulation of intestinal barrier function and gut microbiota | |
| Nowatzky et al. | Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis | |
| EP1744162A4 (en) | Cancer diagnosis and treatment using an anti-ROBO1 antibody | |
| JP2013510158A5 (enExample) | ||
| CN110859950A (zh) | 一种用于白念珠菌棘白菌素类药物耐药菌的药物组合物及其应用 | |
| Soderberg | Increased tumor growth in mice exposed to inhaled isobutyl nitrite |